This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Invitrogen
other brands :
NeoMarkers, Lab Vision, Endogen, Pierce, BioSource International, Zymed Laboratories, Caltag, Molecular Probes, Research Genetics, Life Technologies, Applied Biosystems, GIBCO BRL, ABgene, Dynal, Affinity BioReagents, Nunc, Invitrogen, NatuTec, Oxoid, Richard-Allan Scientific, Arcturus, Perseptive Biosystems, Proxeon, eBioscience
product type :
antibody
product name :
CCDC93 Monoclonal Antibody (OTI2A4)
catalog :
MA5-26449
quantity :
100 uL
price :
US 514.00
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
reactivity :
human, mouse, rat, dogs
application :
western blot
product information
Product Type :
Antibody
Product Name :
CCDC93 Monoclonal Antibody (OTI2A4)
Catalog # :
MA5-26449
Quantity :
100 uL
Price :
US 514.00
Clonality :
Monoclonal
Purity :
Affinity Chromatography
Host :
Mouse
Reactivity :
Canine, Human, Mouse, Non-human primate, Rat
Applications :
Western Blot: 1:500
Species :
Canine, Human, Mouse, Non-human primate, Rat
Clone :
OTI2A4
Isotype :
IgG1
Storage :
-20 C, Avoid Freeze/Thaw Cycles
Description :
CCDC93 is involved in copper-dependent ATP7A trafficking between the trans-Golgi network and vesicles in the cell periphery; the function is proposed to depend on its association within the CCC complex and cooperation with the WASH complex on early endosomes and is dependent on its interaction with WASHC2C.
Immunogen :
Human recombinant protein fragment corresponding to amino acids 293-631 of CCDC93 produced in E.coli
Format :
Liquid
Applications w/Dilutions :
Western Blot: 1:500
Aliases :
4633402D15Rik; 9230102M16Rik; CCDC93; coiled-coil domain containing 93; coiled-coil domain-containing protein 93
company information
Invitrogen
Thermo Fisher Scientific
81 Wyman Street
Waltham, MA USA 02451
https://www.thermofisher.com81 Wyman Street
Waltham, MA USA 02451
800-678-5599
headquarters: USA
questions and comments